mirikizumab
Showing 1 - 15 of 15
Ulcerative Colitis, Ulcerative Colitis Chronic Trial (Mirikizumab)
Not yet recruiting
- Ulcerative Colitis
- Ulcerative Colitis Chronic
- Mirikizumab
- (no location specified)
Mar 6, 2023
Healthy Trial in United States (Mirikizumab)
Recruiting
- Healthy
- Mirikizumab
-
Cypress, California
- +5 more
Dec 26, 2022
Crohn Disease Trial (Mirikizumab)
Not yet recruiting
- Crohn Disease
- Mirikizumab
- (no location specified)
Aug 19, 2022
Healthy Trial in United States (Mirikizumab)
Not yet recruiting
- Healthy
- Mirikizumab
-
Cypress, California
- +5 more
Aug 24, 2022
Ulcerative Colitis, Ulcerative Colitis Chronic, IBD Trial in Worldwide (Mirikizumab)
Recruiting
- Ulcerative Colitis
- +3 more
- Mirikizumab
-
San Francisco, California
- +15 more
Dec 26, 2022
Ulcerative Colitis Trial in Worldwide (Mirikizumab)
Active, not recruiting
- Ulcerative Colitis
- Mirikizumab
-
Orange, California
- +36 more
Aug 17, 2022
Healthy Trial in Springfield (Mirikizumab)
Completed
- Healthy
- Mirikizumab
-
Springfield, MissouriQPS
Jan 28, 2021
Crohn's Disease Trial in Worldwide (Mirikizumab)
Recruiting
- Crohn's Disease
- Mirikizumab
-
Dothan, Alabama
- +318 more
Jan 18, 2023
Ulcerative Colitis Trial in Worldwide (Mirikizumab, Placebo)
Recruiting
- Ulcerative Colitis
- Mirikizumab
- Placebo
-
Dothan, Alabama
- +531 more
Oct 26, 2022
Psoriasis Trial in Anaheim, DeLand, High Point (Drug Cocktail, Mirikizumab)
Completed
- Psoriasis
- Drug Cocktail
- Mirikizumab
-
Anaheim, California
- +2 more
Dec 21, 2019
Ulcerative Colitis Trial in Worldwide (Mirikizumab)
Recruiting
- Ulcerative Colitis
- Mirikizumab
-
Dothan, Alabama
- +350 more
Jan 18, 2023
Crohn's Disease Trial in Worldwide (Mirikizumab, Ustekinumab, Placebo)
Recruiting
- Crohn's Disease
- Mirikizumab
- +2 more
-
Birmingham, Alabama
- +580 more
Aug 17, 2022